热门资讯> 正文
Quince Therapeutics宣布定价高达2200万美元的私募股权;股价上涨22%
2025-06-13 05:31
- Quince Therapeutics (NASDAQ:QNCX) announces a private placement expected to generate $11.5M in upfront proceeds.
- The deal includes common stock (or pre-funded warrants) and accompanying common warrants.
- Warrants could bring in an additional $10.4 M if exercised in full for cash.
- Funds will support working capital and general corporate purposes.
- QNCX shares rise 22% post-market on Thursday.
- Source: Press release
More on Quince Therapeutics
- Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026
- Seeking Alpha’s Quant Rating on Quince Therapeutics
- Historical earnings data for Quince Therapeutics
- Financial information for Quince Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
